Skip to content

Author

J. Q. Reimão

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

C-1 functionalization of the marinoquinoline scaffold generates novel and selective inhibitors of Toxoplasma gondii and Trypanosoma cruzi.

Toxoplasmosis and Chagas disease are parasitic diseases for which current treatments are limited by toxicity and suboptimal efficacy. Marinoquinolines have recently emerged as promising antiparasitic scaffolds, although structural modifications at position 1 of the marinoquinoline core remain unexplored. Herein, we rep...

Tayline Torres, Ana Luiza Moreira Silva, Gabriela P. Dos Santos et al. · 0 citations
Open access Oct 2026

4- O -Allyl Derivative of Natural Licarin A Exhibits Selective In Vitro Activity against Toxoplasma gondii Tachyzoites

Toxoplasma gondii is an obligate intracellular protozoan responsible for toxoplasmosis, a widespread parasitic disease that poses a serious health threat, especially to immunocompromised patients and pregnant women. Current therapeutic options remain unsatisfactory because they are associated with adverse effects and...

Gabriel Cândido Moura, Stephanie Ortega Alves, Ingrid de Oliveira Dias et al. · 0 citations
Open access Sep 2026

Highly Selective Thiazole Derivatives as Promising Anti-Toxoplasma gondii Agents

Toxoplasmosis, caused by the protozoan Toxoplasma gondii, remains a significant global health challenge, particularly for immunocompromised individuals. Current therapies, based on pyrimethamine and sulfadiazine, are limited by toxicity, suboptimal efficacy, and the emergence of resistant parasite strains, highlighting...

Ingrid de Oliveira Dias, Gabriel Cândido Moura, Lucas Manoel da Silva Sousa et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.